323 related articles for article (PubMed ID: 30118686)
1. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.
Ahn SJ; Lee SU; Lee SH; Lee BR
Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686
[TBL] [Abstract][Full Text] [Related]
2. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
[TBL] [Abstract][Full Text] [Related]
5. Review of Retinal Imaging Modalities for Hydroxychloroquine Retinopathy.
Cheong KX; Ong CJT; Chandrasekaran PR; Zhao J; Teo KYC; Mathur R
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238236
[TBL] [Abstract][Full Text] [Related]
6. Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients.
Ahn SJ; Joung J; Lim HW; Lee BR
Am J Ophthalmol; 2017 Dec; 184():11-18. PubMed ID: 28964805
[TBL] [Abstract][Full Text] [Related]
7. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
Ahn SJ; Ryu SJ; Lim HW; Lee BR
Retina; 2019 May; 39(5):1016-1026. PubMed ID: 29373341
[TBL] [Abstract][Full Text] [Related]
8. Choroidal Thinning Associated With Hydroxychloroquine Retinopathy.
Ahn SJ; Ryu SJ; Joung JY; Lee BR
Am J Ophthalmol; 2017 Nov; 183():56-64. PubMed ID: 28890078
[TBL] [Abstract][Full Text] [Related]
9. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
[TBL] [Abstract][Full Text] [Related]
10. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
12. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
[TBL] [Abstract][Full Text] [Related]
14. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
Kellner U; Renner AB; Tillack H
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
Ahn SJ; Seo EJ; Kim KE; Kim YJ; Lee BR; Kim JG; Yoon YH; Lee JY
Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843
[TBL] [Abstract][Full Text] [Related]
16. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
17. Detection of the regression on hydroxychloroquine retinopathy in optical coherence tomography.
Turgut B; Turkcuoglu P; Serdar Koca S; Aydemir O
Clin Rheumatol; 2009 May; 28(5):607-9. PubMed ID: 19221829
[TBL] [Abstract][Full Text] [Related]
18. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
[TBL] [Abstract][Full Text] [Related]
19. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
[TBL] [Abstract][Full Text] [Related]
20. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
Forte R; Haulani H; Dyrda A; Jürgens I
Br J Ophthalmol; 2021 Sep; 105(9):1297-1301. PubMed ID: 30842084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
